Literature DB >> 9167267

Germ-free and barrier-raised TGF beta 1-deficient mice have similar inflammatory lesions.

G P Boivin1, I Ormsby, J Jones-Carson, B A O'Toole, T Doetschman.   

Abstract

Barrier-raised transforming growth factor beta 1 (TGF beta 1)-deficient mice consistently die before 35 days of age of a severe multiorgan inflammatory disease that can affect the skeletal muscle, heart, liver, pancreas, salivary gland, lung, oesophagus and stomach. The underlying cause of this disease is not known. To determine whether abnormal responsiveness of the immune system to the presence of enteric flora plays a causative role, a colony of TGF beta 1-deficient and wild-type mice were raised in a sterile environment. Seven germ-free TGF beta 1-deficient and 5 germ-free TGF beta 1 wild-type mice were examined. Lesion development was analysed and compared with historical data on 50 barrier-raised TGF beta 1 mutant mice and 32 barrier-raised wild-type mice. All germ-free TGF beta 1-deficient mice died shortly after weaning, as do their barrier-raised counterparts. There was a significant delay in death in germ-free TGF beta 1-deficient mice compared with barrier-raised mutant mice. However, there was no difference in the type, severity or incidence of lesions between TGF beta 1 mutant mice raised under germ-free or barrier conditions. Germ-free wild-type mice had no lesions. It is concluded that microorganisms play a minimal role in disease induction in TGF beta 1-deficient mice.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9167267     DOI: 10.1023/a:1018490007745

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  18 in total

Review 1.  Overview of the mucosal immune system.

Authors:  P Brandtzaeg
Journal:  Curr Top Microbiol Immunol       Date:  1989       Impact factor: 4.291

2.  Expression and regulation of beta 7(beta p) integrins on mouse lymphocytes: relevance to the mucosal immune system.

Authors:  P J Kilshaw; S J Murant
Journal:  Eur J Immunol       Date:  1991-10       Impact factor: 5.532

3.  Serum antibody response of gnotobiotic athymic and euthymic mice following alimentary tract colonization and infection with Candida albicans.

Authors:  E Balish; H Filutowicz
Journal:  Can J Microbiol       Date:  1991-03       Impact factor: 2.419

4.  Blood and serum chemistry values of gnotobiotic beagles.

Authors:  C E Yale; E Balish
Journal:  Lab Anim Sci       Date:  1976-08

5.  Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene.

Authors:  B Sadlack; H Merz; H Schorle; A Schimpl; A C Feller; I Horak
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

6.  Transforming growth factor-beta 1 and IL-4 regulate the adhesiveness of Peyer's patch high endothelial venule cells for lymphocytes.

Authors:  Y H Chin; J P Cai; X M Xu
Journal:  J Immunol       Date:  1992-02-15       Impact factor: 5.422

7.  Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease.

Authors:  M M Shull; I Ormsby; A B Kier; S Pawlowski; R J Diebold; M Yin; R Allen; C Sidman; G Proetzel; D Calvin
Journal:  Nature       Date:  1992-10-22       Impact factor: 49.962

8.  SLE-like autoantibodies and Sjögren's syndrome-like lymphoproliferation in TGF-beta knockout mice.

Authors:  H Dang; A G Geiser; J J Letterio; T Nakabayashi; L Kong; G Fernandes; N Talal
Journal:  J Immunol       Date:  1995-09-15       Impact factor: 5.422

9.  Transforming growth factor beta specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes.

Authors:  R L Coffman; D A Lebman; B Shrader
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

10.  The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats.

Authors:  J D Taurog; J A Richardson; J T Croft; W A Simmons; M Zhou; J L Fernández-Sueiro; E Balish; R E Hammer
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

View more
  9 in total

1.  TGF-β puts the brakes on homeostatic proliferation.

Authors:  Charles D Surh; Jonathan Sprent
Journal:  Nat Immunol       Date:  2012-06-19       Impact factor: 25.606

Review 2.  Animal models of intestinal fibrosis: new tools for the understanding of pathogenesis and therapy of human disease.

Authors:  Florian Rieder; Sean Kessler; Miquel Sans; Claudio Fiocchi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-08-09       Impact factor: 4.052

3.  Elimination of both CD4+ and CD8+ T cells but not B cells eliminates inflammation and prolongs the survival of TGFbeta1-deficient mice.

Authors:  Ramireddy Bommireddy; Sandra J Engle; Ilona Ormsby; Gregory P Boivin; George F Babcock; Thomas Doetschman
Journal:  Cell Immunol       Date:  2005-03-29       Impact factor: 4.868

4.  Self-antigen recognition by TGF beta1-deficient T cells causes their activation and systemic inflammation.

Authors:  Ramireddy Bommireddy; Leena J Pathak; Jennifer Martin; Ilona Ormsby; Sandra J Engle; Gregory P Boivin; George F Babcock; Anna U Eriksson; Ram R Singh; Thomas Doetschman
Journal:  Lab Invest       Date:  2006-07-24       Impact factor: 5.662

Review 5.  Regulatory T cells and immune regulation of allergic diseases: roles of IL-10 and TGF-β.

Authors:  O Palomares; M Martín-Fontecha; R Lauener; C Traidl-Hoffmann; O Cavkaytar; M Akdis; C A Akdis
Journal:  Genes Immun       Date:  2014-07-24       Impact factor: 2.676

Review 6.  TGF-beta: a master of all T cell trades.

Authors:  Ming O Li; Richard A Flavell
Journal:  Cell       Date:  2008-08-08       Impact factor: 41.582

7.  Medical therapy of stricturing Crohn's disease: what the gut can learn from other organs - a systematic review.

Authors:  Dominik Bettenworth; Florian Rieder
Journal:  Fibrogenesis Tissue Repair       Date:  2014-03-29

Review 8.  Cytolytic CD4+ and CD8+ Regulatory T-Cells and Implications for Developing Immunotherapies to Combat Graft-Versus-Host Disease.

Authors:  Sara Bolivar-Wagers; Jemma H Larson; Sujeong Jin; Bruce R Blazar
Journal:  Front Immunol       Date:  2022-04-12       Impact factor: 8.786

Review 9.  Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity.

Authors:  Shomyseh Sanjabi; Lauren A Zenewicz; Masahito Kamanaka; Richard A Flavell
Journal:  Curr Opin Pharmacol       Date:  2009-05-29       Impact factor: 5.547

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.